CD8A and colorectal cancer: Rapid-Turnaround Co-Administration of mRNA-Based MHC-I and MHC-II-Restricted Neoantigens Enhances Immune Responses of Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells and Anti-Cancer Efficacy in Colorectal Cancer.